Dec. 15 (Bloomberg) -- Roche Holding AG’s Tamiflu treatment, being stockpiled worldwide for use in a potential avian influenza epidemic, doesn’t need extra safety information on its label, a European Union regulatory panel ruled.
Dec. 15 (Bloomberg) -- Roche Holding AG’s Tamiflu treatment, being stockpiled worldwide for use in a potential avian influenza epidemic, doesn’t need extra safety information on its label, a European Union regulatory panel ruled.
